➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
McKesson
McKinsey
Medtronic
Merck

Last Updated: October 25, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: capmatinib hydrochloride


Email this page to a colleague

« Back to Dashboard

capmatinib hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Novartis Pharm TABRECTA capmatinib hydrochloride TABLET;ORAL 213591 NDA Novartis Pharmaceuticals Corporation 0078-0709-56 56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-56) 2020-05-06
Novartis Pharm TABRECTA capmatinib hydrochloride TABLET;ORAL 213591 NDA Novartis Pharmaceuticals Corporation 0078-0709-94 56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-94) 2020-05-06
Novartis Pharm TABRECTA capmatinib hydrochloride TABLET;ORAL 213591 NDA Novartis Pharmaceuticals Corporation 0078-0716-56 56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-56) 2020-05-06
Novartis Pharm TABRECTA capmatinib hydrochloride TABLET;ORAL 213591 NDA Novartis Pharmaceuticals Corporation 0078-0716-94 56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-94) 2020-05-06
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Baxter
Colorcon
Harvard Business School
Dow